Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4207513
Max Phase: Preclinical
Molecular Formula: C22H25N3O4
Molecular Weight: 395.46
Molecule Type: Small molecule
Associated Items:
ID: ALA4207513
Max Phase: Preclinical
Molecular Formula: C22H25N3O4
Molecular Weight: 395.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)c1cc(=O)c2cc(NC(=O)NC34CC5CC(CC(C5)C3)C4)ccc2[nH]1
Standard InChI: InChI=1S/C22H25N3O4/c1-29-20(27)18-8-19(26)16-7-15(2-3-17(16)24-18)23-21(28)25-22-9-12-4-13(10-22)6-14(5-12)11-22/h2-3,7-8,12-14H,4-6,9-11H2,1H3,(H,24,26)(H2,23,25,28)
Standard InChI Key: GCJOAIWENCAGKV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 395.46 | Molecular Weight (Monoisotopic): 395.1845 | AlogP: 3.41 | #Rotatable Bonds: 3 |
Polar Surface Area: 100.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.79 | CX Basic pKa: | CX LogP: 3.18 | CX LogD: 2.55 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.69 | Np Likeness Score: -0.94 |
1. Ling T, Lang W, Feng X, Das S, Maier J, Jeffries C, Shelat A, Rivas F.. (2018) Novel vitexin-inspired scaffold against leukemia., 146 [PMID:29407975] [10.1016/j.ejmech.2018.01.004] |
Source(1):